Luye Pharma Group Ltd
HKEX:2186
Intrinsic Value
The intrinsic value of one
Luye Pharma Group Ltd
stock under the Base Case scenario is
5.26
HKD.
Compared to the current market price of 3.01 HKD,
Luye Pharma Group Ltd
is
Undervalued by 43%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Luye Pharma Group Ltd.
Fundamental Analysis
Revenue & Expenses Breakdown
Luye Pharma Group Ltd
Balance Sheet Decomposition
Luye Pharma Group Ltd
| Current Assets | 15.7B |
| Cash & Short-Term Investments | 8.8B |
| Receivables | 3.5B |
| Other Current Assets | 3.3B |
| Non-Current Assets | 16.3B |
| Long-Term Investments | 2.5B |
| PP&E | 5.9B |
| Intangibles | 7.8B |
| Other Non-Current Assets | 111.7m |
Free Cash Flow Analysis
Luye Pharma Group Ltd
| CNY | |
| Free Cash Flow | CNY |
Earnings Waterfall
Luye Pharma Group Ltd
|
Revenue
|
6.2B
CNY
|
|
Cost of Revenue
|
-2B
CNY
|
|
Gross Profit
|
4.1B
CNY
|
|
Operating Expenses
|
-2.7B
CNY
|
|
Operating Income
|
1.4B
CNY
|
|
Other Expenses
|
-1B
CNY
|
|
Net Income
|
396.9m
CNY
|
Profitability Score
Profitability Due Diligence
Luye Pharma Group Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Score
Luye Pharma Group Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Luye Pharma Group Ltd's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Luye Pharma Group Ltd's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Luye Pharma Group Ltd
According to Wall Street analysts, the average 1-year price target for
Luye Pharma Group Ltd
is 4.44 HKD
with a low forecast of 3.74 HKD and a high forecast of 5.25 HKD.
Dividends
Current shareholder yield for
Luye Pharma Group Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Luye Pharma Group Ltd
stock under the Base Case scenario is
5.26
HKD.
Compared to the current market price of 3.01 HKD,
Luye Pharma Group Ltd
is
Undervalued by 43%.